Prostacyclin modulates granulocyte/macrophage colony-stimulating factor release by human blood mononuclear cells

Pulmonary Pharmacology

Volumn 9, Issue 1, 1996, Pages 43-48

  Luttmann, W ^a   Herzog, V ^a   Virchow Jr , J C ^a   Matthys, H ^a   Thierauch, K H ^b   Kroegel, C ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

Cicaprost; Endotoxin; GM CSF secretion and mRNA expression; Granulocyte macrophage colony stimulating factor; Mononuclear cells; Prostaglandin I2

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CICAPROST; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; PROSTACYCLIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030088024     PISSN: 09520600     EISSN: None     Source Type: Journal    
DOI: 10.1006/pulp.1996.0005     Document Type: Article

References (22)

1. 1. Metcalf C. The granulocyte-macrophage colony stimulating factors. Science 1992; 254: 529-542.
2. 2. Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor Blood 1991; 77: 1131-1145.
3. 3. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosoled prostacyclin in adult respiratory distress syndrome. Lancet 1993; 342: 961-962.
4. 4. Rademacher P, Santak B, Wüst HJ, Tarrow J, Falke KJ. Prostacyclin and right ventricular functions in patients with pulmonary hypertension associated with ARDS. Intensive Care Med 1990; 16: 227-232.
5. 5. Strieter RM, Remick DG, Lynch JP III, Gernod M, Raiford C, Spengler R, Kunkel SL. Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis. Am J Respir Cell Mol Biol 1989; 1: 57-63.
6. 6. Luttmann W, Knöchel B, Förster M, Matthys H, Virchow JC jr, Kroegel C. Activation of human blood eosinophils by interleukin-13. J Immunol, 1996, in press.
7. 7. Laver J, Moore MAS. Clinical use of recombinant human hematopoietic growth factors. J Natl Cancer Inst 1989; 81: 1370-1382.
8. 8. Silberstein D, Austen KF, Owen WF, Gasson JC, DiPersio JF, Golde DW, Bina JC, Soberman R, Austen KF, David JR. Enhancement of human eosinophilic cytotoxicity and leukotriene synthesis by recombinant granulocyte-macrophage colony-stimulating factor. J Immunol 1986; 137: 3290-3294.
9. 2 production by mouse Kupffer cells. Prostaglandins, Leukot & Essent Fatty Acids 1990; 40: 275-279.
10. 10. Marcinkiwicz J, Chain BM. Differential cytokine regulation by eicosanoids in T cells primed by contact sensitization with TNP. Cell Immunol 1993; 149: 303-314.
11. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988; 263: 5380-5384.
12. 12. Crutchley DJ, Conanan LB, Que BG. Effects of prostacyclin analogues on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1beta in human monocytic THP-1 cells. J Pharmacol Exper Therap 1994; 271: 446-451.
13. 13. Williams JH, Patel SK, Hatakeyama D, Arian R, Guo K, Hickey TJ, Liao S-Y, Ulich TR. Activated pulmonary vascular neutrophils as early mediators of endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 1993; 8: 134-144.
14. 14. Idell S, Cohen AB. Bronchoalveolar lavage in patients with the adult respiratory distress syndrome. Clin Chest Med 1985; 6: 459-471.
15. 15. Lee CT, Fein AM, Lippman M, Holtzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage from patients with adult respiratory distress syndrome. N Engl J Med 1981; 304: 192-196.
16. 16. Opal SM, Palardy JE, Marra MN, Fisher CJ, McKelligon BM, Scott RW. Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 1994; 344: 429-431.
17. 17. Spolarics Z, Schuler A, Bagby GJ, Lang CH, Nelson S, Spitzer JJ. In vivo metabolic response of hepatic nonparenchymal cells and leukocytes to granulocyte-macrophage colony-stimulating factor. J Leukoc Biol 1992; 51: 360-365.
18. 18. Toda H, Murata A, Oka Y, Uda K, Tanaka N, Ohashi I, Mori T, Matsura N. Effect of granulocyte-macrophage colony-stimulating factor on sepsis-induced organ injury in rats. Blood 1994; 83: 2893-2898.
19. 19. Verhoef G, Boogaerts M. Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome. Am J Heamatol 1991; 36: 285-287.
20. 20. Terashima T, Kanazawa M, Sayama K, Ishizaka A, Urana T, Sakamaki F, Nakamura H, Waki Y, Tasaka S. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pig. Am J Respir Crit Care Med 1994; 149: 1295-1303.
21. 21. Moncada S, Vane JR. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Pharmacol Rev 1979; 30: 293-321.
22. 22. MacDonald PS, Read MA, Dusting GJ. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Throm Res 1988; 9: 437-443.